Rearrangements of 3-Aza-1,2,5-hexatrienes
J . Org. Chem., Vol. 61, No. 1, 1996 61
7.2 Hz), 1.53 (d, 3H, J ) 7.2 Hz); 13C NMR (75 MHz, CDCl3)
δ 173.9, 141.3, 134.1, 128.8, 127.6, 127.2, 115.8, 47.0, 41.8, 18.4.
Anal. Calcd for C12H15NO: C, 76.14; H, 7.99. Found: C, 75.99;
H, 7.95.
2-Meth yl-2-p h en yl-4-p en ten en itr ile (4c). Procedure A
was used (60%): IR (neat) 2987, 2241, 1498, 1451, 927, 765,
698 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.42-18 (m, 5H), 5.71-
5.55 (m, 1H), 5.12-5.01 (m, 2H), 2.65-2.46 (m, 2H), 1.64 (s,
3H); 13C NMR (75 MHz, CDCl3) δ 139.7, 131.8, 128.8, 127.8,
125.5, 123.1, 120.1, 46.26, 42.11, 26.5; MS (GC-E/I) m/ e 171
(18.68), 131 (10.06), 130 (100), 103 (40.30), 77 (13.62), 51 (4.71).
2,2-Dip h en yl-4-p en ten en itr ile (4d ). Amide 1d (158.7 mg,
0.830 mmol) was submitted to procedure A above. Purification
gave 107.4 mg of the nitrile (75%): IR (neat) 3062, 2237, 1493,
N-Allyl-2,2-d ip h en yla ceta m id e (1d ): IR (CH2Cl2) 3428,
1
3029, 1670, 1510 cm-1; H NMR (300 MHz, CDCl3) δ 7.38-
7.16 (m, 10H), 5.90-5.70 (m, 2H), 5.10-5.00 (m, 2H), 4.94 (s,
1H), 3.89 (tt, 2H, J app ) 5.6, 1.6 Hz); 13C NMR (75 MHz, CDCl3)
δ 171.8, 139.6, 134.2, 129.0, 128.9, 127.4, 116.4, 59.3, 42.2; MS
(GC-E/I) m/ e 251 (M+, 4), 168 (100), 152 (21), 41 (26). Anal.
Calcd for C17H17NO: C, 81.24; H, 6.82; N, 5.57. Found: C,
81.33; H, 6.85; N, 5.70.
1
1449, 697 cm-1; H NMR (300 MHz, CDCl3) δ 7.42-7.20 (m,
10H), 5.80-5.61 (m, 2H), 5.27-5.10 (m, 2H), 3.13 (dt, 2H, J app
) 6.8, 1.2 Hz); 13C NMR (75 MHz, CDCl3) δ 139.8, 131.9, 129.0,
128.1, 127.2, 122.1, 120.5, 51.8, 44.0; MS (GC-E/I) m/ e 233
(M+, 9), 192 (73), 165 (100). Anal. Calcd for C17H15N: C,
87.52; H, 6.48; N, 6.00. Found: C, 87.78; H, 6.46; N, 5.80.
2-(4-Meth oxyp h en yl)-4-p en ten en itr ile (4e). Amide le
(127.2 mg, 0.620 mmol) was submitted to procedure A above.
The standard pruification procedure gave 100.0 mg of the
nitrile (85%): IR (neat) 2961, 2241, 1513, 1256 cm-1; 1H NMR
(300 MHz, CDCl3) δ 7.24, 6.90 (ABq, 4H, J AB ) 8.9 Hz), 5.90-
5.69 (m, 1H), 5.24-5.11 (m, 2H), 3.80 (s, 3H), 2.66-2.53 (m,
N-Allyl-2-(4-m eth oxyp h en yl)a ceta m id e (1e): IR (CH2-
1
Cl2) 3428, 2936, 1670, 1513, 1249 cm-1; H NMR (300 MHz,
CDCl3) δ 7.18, 6.90, (app t ABq, 4H, J ) 2.6 Hz, J AB ) 8.8
Hz), 5.83-5.70 (m, 1H), 5.45 (br s, 1H), 5.09-5.00 (m, 2H),
3.87-3.80 (m, 2H), 3.81 (s, 3H), 3.55 (s, 2H); 13C NMR (75
MHz, CDCl3) δ 171.2, 158.8, 134.0, 130.5, 126.7, 115.9, 114.4,
55.2, 42.8, 41.8; MS (GC-E/I) m/ e 205 (M+, 17), 121 (100).
Anal. Calcd for C12H15NO2: C, 70.20; H, 7.37; N, 6.82.
Found: C, 70.07; H, 7.34; N, 6.52.
N-Allyl-2-(4-(tr iflu or om eth yl)p h en yl)a ceta m id e (1f): IR
(CH2Cl2) 3428, 3336, 2922, 1677, 1514, 1327, 1168, 1127 cm-1
;
2H);
13C NMR (75 MHz, CDCl3) δ 159.5, 132.8, 128.6, 127.3,
1H NMR (300 MHz, CDCl3) δ 7.61, 7.41 (ABq, 4H, J AB ) 8.2
Hz), 5.87-5.70 (m, 1H), 5.60 (br s, 1H), 5.13-5.05 (m, 2H),
3.89-3.83 (m, 2H), 3.63 (s, 2H); 13C NMR (75 MHz, CDCl3) δ
170.1, 139.3, 133.9, 129.7, 129.3, 125.7 (unresolved q, J ) 4
Hz), 124.2 (q, J ) 272 Hz), 116.4, 43.2, 42.2. Anal. Calcd for
C12H12F3NO: C, 59.26; H, 4.94; N, 5.76; MS (GC-E/I) m/ e 243
(M+, 17), 158 (70), 84 (53), 57 (35), 41 (100). Found: C, 59.03;
H, 4.93; N, 5.54.
120.7, 119.4, 114.5, 55.4, 40.0, 36.8; MS (GC-E/I) m/ e 187
(M+, 1), 158 (9), 91 (100), 65 (9).
2-(4-(Tr iflu or om et h yl)p h en yl)-4-p en t en en it r ile (4f).
Amide 1f (133.2 mg, 0.548 mmol) was submitted to procedure
A above. Purification gave 90.6 mg of the nitrile (73%): IR
(neat) 2926, 2243, 1326, 1168, 1128, 1069-1 1H NMR (300
;
MHz, CDCl3) δ 7.66, 7.47 (ABq, 4H, J AB ) 8.06 Hz), 5.90-
5.60 (m, 1H), 5.31-5.13 (m, 2H), 3.94 (t, 1H, J ) 7.08 Hz),
2.72-2.59 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 139.2, 132.0,
130.5, 128.0, 126.2 (unresolved q, J ) 3 Hz), 123.9 (q, J ) 273
Hz), 120.2, 119.8, 39.7, 37.5; MS (GC-E/I) m/ e 225 (M+, 98),
184 (100), 134 (80), 41 (99). Anal. Calcd for C12H10F3N: C,
64.00; H, 4.48; N, 6.22. Found: C, 63.96; H, 4.74; N, 6.07.
Meth yl 3-Cya n o-5-h exen oa te (4g). Procedure A was used
(69%): IR (neat) 2959, 2244, 1740, 1438, 1212, 1176 cm-1; 1H
NMR (300 MHz, CDCl3) δ 5.88-5.72 (m, 1H), 5.29-5.16 (m,
2H), 3.73 (s, 3H), 3.16-3.04 (m, 1H), 2.75-2.53 (m, 2H), 2.45-
2.36 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 170.1, 132.1, 120.5,
119.8, 52.2, 35.6, 27.1. Anal. Calcd for C8H11NO2: C, 62.71;
H, 7.24. Found: C, 62.64; H, 7.16.
Meth yl 3-(N-Allylca r ba m oyl)p r op a n oa te (1g): IR (neat)
3301, 3085, 2950, 1738, 1653, 1549, 1167 cm-1; 1H NMR (300
MHz, CDCl3) δ 6.26 (br s, 1H), 5.84-5.66 (m, 1H), 5.20-4.98
(m, 2H), 3.80 (tt, 2H, J app ) 5.7, 1.5 Hz), 3.62 (s, 3H), 2.61 (t,
2H, J ) 6.7 Hz), 2.45 (t, 2H, J ) 6.7 Hz); 13C NMR (75 MHz,
CDCl3) δ 173.3, 171.2, 134.0, 115.9, 51.6, 41.8, 30.6, 29.2; MS
(EI) m/ e 157 (17), 116 (100), 89 (23), 87 (21), 63 (18), 57 (44).
Anal. Calcd for C8H13NO3: C, 56.11; H, 7.66. Found: C, 55.04;
H, 7.86.
N-Allyl-5-br om op en ta n a m id e (1i): 1H NMR (300 MHz,
CDCl3) δ 6.15 (br s, 1H), 5.91-5.78 (m, 1H), 5.24-5.10 (m,
2H), 3.87 (tt, 2H, J app ) 5.7, 1.5 Hz), 3.43 (t, 2H, J ) 6.5 Hz),
2.26 (t, 2H, J ) 7.2 Hz), 1.97-1.74 (m, 4H); 13C NMR (75 MHz,
CDCl3) δ 172.5, 134.3, 116.4, 42.0, 35.5, 33.4, 32.2, 24.3.
N-Allyl-2-(ben zyloxy)a ceta m id e (1j): 1H NMR (300 MHz,
CDCl3) δ 7.40-7.28 (m, 5H), 6.72 (br s, 1H), 5.90-5.76 (m,
1H), 5.26-5.10 (m, 2H), 4.56 (s, 2H), 4.00 (s, 2H), 3.91 (tt, 2H,
J app ) 5.9, 1.5 Hz); 13C NMR (75 MHz, CDCl3) δ 169.4, 136.8,
134.0, 128.7, 128.3, 128.0, 116.4, 73.6. 69.5, 41.2. Anal. Calcd
for C12H15NO2: C, 70.22; H, 7.37; N, 6.82. Found: C, 69.82;
H, 7.47; N, 6.78.
N-Allyl-(2-m eth oxym eth oxy)a ceta m id e (1k ): IR (neat)
3336, 2934, 1666, 1538, 1152, 1115, 1055, 920 cm-1; 1H NMR
(300 MHz, CDCl3) δ 6.72 (br s, 1H), 5.94-5.77 (m, 1H), 5.28-
5.11 (m, 2H), 4.69 (s, 2H), 4.07 (s, 2H), 3.95 (tt, 2H, J app ) 5.7,
1.5 Hz), 3.40 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 169.2, 134.0,
116.5, 96.6, 67.1, 55.8, 41.2.
2-(3-Br om opr opyl)-4-pen ten en itr ile (4i). Amide 1i (145.9
mg, 0.663 mmol) was submitted to procedure B above. The
standard purification procedure gave 59.7 mg of the nitrile
(45%): IR (neat) 3085, 2946, 2871, 2240, 1649, 1442, 1250,
995, 922 cm-1 1H NMR (300 MHz, CDCl3) δ 5.88-5.73 (m,
;
1H), 5.23-5.15 (m, 1H), 3.43 (t, 2H, J ) 6.4 Hz), 2.69-2.57
(m, 1H), 2.36 (t, 2H, J ) 6.9 Hz), 2.20-1.88 (m, 2H), 1.88-
1.65 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 132.7, 121.1, 119.1,
36.1, 32.3, 30.7, 30.0, 29.8; MS (E/I) m/ e 203 (1.4), 202 (0.5),
201 (1.5), 122 (34), 95 (20), 94 (79), 81 (11), 80 (30), 53 (100).
Anal. Calcd for C8H12BrN: C, 47.76; H, 6.02. Found: C,
47.50; H, 5.84.
2-(Ben zyloxy)-4-p en ten en itr ile (4j). Amide 1j (59.3 mg,
0.288 mmol) was submitted to procedure F above. Purification
gave 21.8 mg of the nitrile (40%): 1H NMR (300 MHz, CDCl3)
δ 7.42-7.28 (m, 5H), 5.90-5.74 (m, 1H), 5.32-5.20 (m, 2H),
4.86, 4.54 (ABq, 2H, J AB ) 11.5 Hz, 1H), 4.19 (t, 1H, J ) 6.5
Hz), 2.61 (tt, 2H, J app ) 6.8, 1.2 Hz); 13C NMR (75 MHz, CDCl3)
δ 136.0, 130.8, 128.8, 128.7, 128.4, 120.2, 118.0, 72.4, 67.5, 37.8.
2-(Meth oxym eth oxy)-4-p en ten en itr ile (4k ) via P r oce-
d u r e F . Amide 1k (0.2570 g, 1.61 mmol) was submitted to
procedure F above. Purification gave 134.4 mg of the nitrile
(59%): 1H NMR (300 MHz, CDCl3) δ 5.92-5.76 (m, 1H), 5.34-
5.22 (m, 2H), 4.85, 4.68 (ABq, 2H, J AB ) 7.1 Hz), 4.41 (t, 1H,
N-Allyl-2-p h th a lyla ceta m id e (1l): 1H NMR (300 MHz,
DMSO-d6) δ 8.44 (br s, 1H), 7.96-7.81 (m, 4H), 5.87-5.69 (m,
1H), 5.19-5.00 (m, 2H), 4.21 (s, 2H), 3.70 (br t, 2H, J app ) 5.2
Hz); 1H NMR (300 MHz, CDCl3) δ 7.80 (m, 4H), 5.90-5.68 (m,
2H), 5.28-5.10 (m, 2H), 4.37 (s, 2H), 3.92 (tt, 2H, J app ) 5.7,
1.5 Hz); 13C NMR (75 MHz, DMSO-d6) δ 167.6, 165.9, 134.8,
134.5, 131.8, 123.2, 115.2, 40.9, 40.1. Anal. Calcd for
C13H12N2O3: C, 63.93; H, 4.95; N, 11.47. Found: C, 63.78; H,
4.95; N, 11.23.
J ) 6.6 Hz)), 3.42 (s, 3H), 2.61 (tt, 2H, J app ) 6.8, 1.2 Hz); 13
C
2-Ben zyl-4-p en ten en itr ile (4b). Procedure A was used
(67%): IR (neat) 3038, 2927, 2243, 1503, 1459, 924, 700 cm-1
;
NMR (75 MHz, CDCl3) δ 130.8, 120.4, 118.1, 95.7, 64.6, 56.4,
1H NMR (300 MHz, CDCl3) δ 7.30-7.12 (m, 5H), 5.85-5.68
(m, 1H), 5.20-5.06 (m, 2H), 2.90-2.70 (m, 3H), 2.33-2.24 (m,
2H); 13C NMR (75 MHz, CDCl3) δ 136.7, 132.5, 129.0, 128.7,
127.2, 121.2, 119.2, 37.6, 35.6, 33.5; MS (GC-E/I) m/ e 171
(2.31), 129 (4.66), 103 (2.21), 92 (13.82), 91 (100), 77 (4.34), 65
(9.44), 51 (3.91). Anal. Calcd for C12H13N: C, 84.16; H, 7.66.
Found: C, 83.81; H, 7.76.
38.0.
2-P h th alyl-4-pen ten en itr ile (4l) via P r ocedu r e B. Amide
1l (46.8 mg, 0.192 mmol) was submitted to procedure B above.
Purification gave 33.8 mg of the nitrile (78%): 1H NMR (300
MHz, CDCl3) δ 7.90-7.70 (m, 4H), 5.75-5.62 (m, 1H), 5.25-
5.10 (m, 3H), 3.00-2.80 (m, 2H); 13C NMR (75 MHz, CDCl3) δ
165.9, 134.7, 131.0, 130.2, 123.9, 121.1, 115.5, 39.1, 35.5. Anal.